Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Jun. 27, 2026 |
Jun. 28, 2025 |
Jun. 27, 2026 |
Jun. 28, 2025 |
Dec. 31, 2024 |
|
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||||
| Asset impairment | $ 13,037 | $ 0 | $ 13,037 | $ 0 | |
| BioNova | SWEN Impact Fund for Transition 3 | |||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||||
| Shares funded (in shares) | 111,111 | ||||
| Noncontrolling percentage | 14.00% | ||||
| X | ||||||||||
- Definition Redeemable Noncontrolling Interest, Shares Issued No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss for asset. Includes, but is not limited to, tangible and intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|